{"organizations": [], "uuid": "5f55a459015e9e6b5d9199365fd03e4b5129b8fd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "in.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/INbusinessNews\r", "section_title": "Reuters: Money News", "url": "https://in.reuters.com/article/aurobindo-pharm-results/aurobindo-pharma-fourth-quarter-profit-misses-estimates-idINKCN1IT1EG", "country": "US", "domain_rank": 408, "title": "Aurobindo Pharma fourth-quarter profit misses estimates", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-28T17:10:00.000+03:00", "replies_count": 0, "uuid": "5f55a459015e9e6b5d9199365fd03e4b5129b8fd"}, "author": "", "url": "https://in.reuters.com/article/aurobindo-pharm-results/aurobindo-pharma-fourth-quarter-profit-misses-estimates-idINKCN1IT1EG", "ord_in_thread": 0, "title": "Aurobindo Pharma fourth-quarter profit misses estimates", "locations": [], "entities": {"persons": [], "locations": [{"name": "india", "sentiment": "none"}], "organizations": [{"name": "aurobindo pharma", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "aurobindo pharma ltd", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Reuters) - India’s Aurobindo Pharma Ltd posted a 0.6 percent fall in fourth-quarter net profit on Monday that missed analysts’ estimates.\nNet profit came in at 5.29 billion rupees ($78.49 million) in the quarter ended March 31, compared with 5.32 billion rupees a year earlier, the Hyderabad-headquartered drugmaker said.\nAnalysts on average had expected a profit of 5.98 billion rupees, according to Thomson Reuters data.\nNet sales rose over 11 percent to 39.89 billion rupees.\n($1 = 67.3950 Indian rupees)\nReporting By Arnab Paul and Aby Jose Koilparambil in Bengaluru; Editing by Edmund Blair\n ", "external_links": [], "published": "2018-05-28T17:10:00.000+03:00", "crawled": "2018-05-28T17:46:51.005+03:00", "highlightTitle": ""}